Cohera Medical Names William M. Cotter as Company's First Vice President of Manufacturing
The addition of Cotter, who has over 29 years of manufacturing and operations experience in the medical device, diagnostics, biologics and life science industries, comes at a time when Cohera Medical is preparing to enter the clinical stage of development with its lead surgical adhesive product, TissuGlu(R).
"Bill brings to Cohera extensive industry knowledge and experience guiding product manufacturing from early-stage R&D through worldwide commercialization," said
Cotter spent 10 years as the vice president of operations for Closure Medical Corporation a medical device company, acquired by Johnson & Johnson, which developed the world's first synthetic topical skin adhesive to be approved by the U.S. Food and Drug Administration. Prior to Closure Medical, he was vice president of operations with Sanofi Diagnostics Pasteur, where he had direct responsibility for all North American manufacturing sites and chaired the worldwide manufacturing committee. Bill is listed as co-inventor on 8 U.S. patents and has a bachelor's degree from
About Cohera Medical
Cohera Medical Inc. is a
Certain statements made throughout this press release that are not historical facts contain forward-looking statements regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements.
SOURCE Cohera Medical, Inc.
More by this Source
Cohera Medical, Inc® Is Named A 2013 Gold Edison Award Winner
May 01, 2013, 08:00 ET
First Patient Treated In Study Of Cohera Medical's Sylys™ Surgical Sealant
Apr 23, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.